What does PHARMACIE DEGIMBE - HAUFROID do?

PHARMACIE DEGIMBE - HAUFROID is a logistics company in Gesves. Private Limited, started on 17 April 2000, 1 establishment.

What is the address of PHARMACIE DEGIMBE - HAUFROID?

The registered office of PHARMACIE DEGIMBE - HAUFROID is located at Chaussée de Gramptinne 159, 5340 Gesves.

Is PHARMACIE DEGIMBE - HAUFROID still active?

Yes. According to the CBE (18 September 2026) PHARMACIE DEGIMBE - HAUFROID is active, legal situation “Normale toestand”, started on 17 April 2000.

Is PHARMACIE DEGIMBE - HAUFROID registered on Peppol?

Yes, PHARMACIE DEGIMBE - HAUFROID is registered on the Peppol network with ID 0208:0471706248.

What is the enterprise number of PHARMACIE DEGIMBE - HAUFROID?

The enterprise number of PHARMACIE DEGIMBE - HAUFROID is BE0471706248.

When was PHARMACIE DEGIMBE - HAUFROID founded?

PHARMACIE DEGIMBE - HAUFROID was founded on 17 April 2000.

Who are the directors of PHARMACIE DEGIMBE - HAUFROID?

According to the 2025 annual accounts, the directors of PHARMACIE DEGIMBE - HAUFROID are: ANNE HAUFROID PASCALE, GEORGES DEGIMBE JEAN-MARC.

Is PHARMACIE DEGIMBE - HAUFROID a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 April 2000; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE DEGIMBE - HAUFROID make in 2025?

PHARMACIE DEGIMBE - HAUFROID posted a profit after taxes of € 47,846 in financial year 2025.

What is the revenue of PHARMACIE DEGIMBE - HAUFROID?

As a small company, PHARMACIE DEGIMBE - HAUFROID is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 179,981.

PHARMACIE DEGIMBE - HAUFROID (Private Limited) - Gesves

Dossier PHARMACIE DEGIMBE - HAUFROID, printed on 18 September 2026 from databakkes.be/en/0471706248/pharmacie-degimbe-haufroid. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DEGIMBE - HAUFROID from Gesves, company number BE0471706248, closed financial year 2025 with a result of € 47,846 after tax. For that financial year PHARMACIE DEGIMBE - HAUFROID recorded a gross margin of € 179,981 and equity of € 186,847. Compared with financial year 2024, the result moved from € 66,226 to € 47,846. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Healthy

€ 186,847

▼ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 47,846

▼ 28% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 71,185

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 104,627 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 107,462

▲ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,304

▲ 130% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 6,816

▼ 73% vs 2024

€ 3,848 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 49,177

▲ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,807

▼ 29% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 210,693 Gross margin 2022: € 210,693 First fiscal year in the series	€ 224,132 Gross margin 2023: € 224,132 ▲ 6% vs 2022 (€ 210,693) Favourable step	€ 218,304 Gross margin 2024: € 218,304 ▼ 3% vs 2023 (€ 224,132) Unfavourable step	€ 179,981 Gross margin 2025: € 179,981 ▼ 18% vs 2024 (€ 218,304) Unfavourable step	▼ 18%
Profit after taxes	€ 47,658 Profit after taxes 2022: € 47,658 First fiscal year in the series	€ 60,845 Profit after taxes 2023: € 60,845 ▲ 28% vs 2022 (€ 47,658) Favourable step	€ 66,226 Profit after taxes 2024: € 66,226 ▲ 9% vs 2023 (€ 60,845) Favourable step	€ 47,846 Profit after taxes 2025: € 47,846 ▼ 28% vs 2024 (€ 66,226) Unfavourable step	▼ 28%
Equity	€ 116,557 Equity 2022: € 116,557 First fiscal year in the series	€ 177,402 Equity 2023: € 177,402 ▲ 52% vs 2022 (€ 116,557) Favourable step	€ 243,628 Equity 2024: € 243,628 ▲ 37% vs 2023 (€ 177,402) Favourable step	€ 186,847 Equity 2025: € 186,847 ▼ 23% vs 2024 (€ 243,628) Unfavourable step	▼ 23%
Total debts	€ 221,444 Total debts 2022: € 221,444 First fiscal year in the series	€ 177,874 Total debts 2023: € 177,874 ▼ 20% vs 2022 (€ 221,444) Favourable step	€ 100,616 Total debts 2024: € 100,616 ▼ 43% vs 2023 (€ 177,874) Favourable step	€ 164,772 Total debts 2025: € 164,772 ▲ 64% vs 2024 (€ 100,616) Unfavourable step	▲ 64%
Cash	€ 66,693 Cash 2022: € 66,693 First fiscal year in the series	€ 25,537 Cash 2023: € 25,537 ▼ 62% vs 2022 (€ 66,693) Unfavourable step	€ 92,153 Cash 2024: € 92,153 ▲ 261% vs 2023 (€ 25,537) Favourable step	€ 71,185 Cash 2025: € 71,185 ▼ 23% vs 2024 (€ 92,153) Unfavourable step	▼ 23%
Land & buildings	€ 179 Land & buildings 2022: € 179 First fiscal year in the series	-	-	-
Retained profit	€ 110,357 Retained profit 2022: € 110,357 First fiscal year in the series	€ 171,202 Retained profit 2023: € 171,202 ▲ 55% vs 2022 (€ 110,357) Favourable step	€ 237,428 Retained profit 2024: € 237,428 ▲ 39% vs 2023 (€ 171,202) Favourable step	€ 180,647 Retained profit 2025: € 180,647 ▼ 24% vs 2024 (€ 237,428) Unfavourable step	▼ 24%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 104,627 Dividend 2025: € 104,627 Unchanged (€ 0) Unchanged
Bank debt	€ 89,225 Bank debt 2022: € 89,225 First fiscal year in the series	€ 61,342 Bank debt 2023: € 61,342 ▼ 31% vs 2022 (€ 89,225) Favourable step	€ 25,413 Bank debt 2024: € 25,413 ▼ 59% vs 2023 (€ 61,342) Favourable step	€ 6,816 Bank debt 2025: € 6,816 ▼ 73% vs 2024 (€ 25,413) Favourable step	▼ 73%
Balance sheet total	€ 338,001 Balance sheet total 2022: € 338,001 First fiscal year in the series	€ 355,276 Balance sheet total 2023: € 355,276 ▲ 5% vs 2022 (€ 338,001) Unchanged	€ 344,245 Balance sheet total 2024: € 344,245 ▼ 3% vs 2023 (€ 355,276) Unchanged	€ 351,620 Balance sheet total 2025: € 351,620 ▲ 2% vs 2024 (€ 344,245) Unchanged	▲ 2%

Key figures of PHARMACIE DEGIMBE - HAUFROID, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DEGIMBE - HAUFROID?

What happened at PHARMACIE DEGIMBE - HAUFROID in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 8, 2026 New annual accounts for financial year 2025: profit of € 47,846 (▼ 28% vs 2024). Source: NBB ↗
May 2, 2000 New establishment in Gesves. KBO
Apr 17, 2000 Start of the company according to the CBE. KBO

In short

From € 47,658 profit in 2022 to € 47,846 profit in 2025.

Paid € 93,672 in corporate taxes since 2022.

Best year ever: 2024, with € 66,226 profit.

Paid out € 104,627 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DEGIMBE - HAUFROID? We notify you, reason included.

Follow PHARMACIE DEGIMBE - HAUFROID

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ANNE HAUFROID PASCALE GEORGES DEGIMBE JEAN-MARC

PHARMACIE DEGIMBE - HAUFROID

Behind PHARMACIE DEGIMBE - HAUFROID are ANNE HAUFROID PASCALE and GEORGES DEGIMBE JEAN-MARC.

See the full network in the app

Directors

According to the 2025 annual accounts

ANNE HAUFROID PASCALE

Director

GEORGES DEGIMBE JEAN-MARC

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Gramptinne 159

5340 Gesves

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0471.706.248

VAT number

BE 0471.706.248

Registered office

Chaussée de Gramptinne 159, 5340 Gesves

Names & denominations

PHARMACIE DEGIMBE - HAUFROID

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 April 2000

Peppol

Active · Active since 11 Dec 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DEGIMBE - HAUFROID

Financials

What happened to PHARMACIE DEGIMBE - HAUFROID?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions